Fiorentino E, Coppotelli L, Pergolini M, Carlizzi G, Basili S, Spanò G, Cordova C
Istituto di Terapia Medica, Università degli Studi di Roma La Sapienza.
Clin Ter. 1992 Jan;140(1):17-23.
The authors report a case of chronic lymphocytic leukemia with thrombocytopenia caused by antiplatelet antibodies. The customary treatments of this condition having proved ineffective, therapy with large I.V. doses of Ig (0.4 g/kg body weight daily for five consecutive days) was started, which is believed to increase platelet count although the mechanism of this action is not yet fully understood. Interesting changes in laboratory parameters were observed, especially those concerning electroimmunophoresis and immunofixation and these might be useful for a better understanding of the various hypotheses that have been put forward to account for the mechanism(s) of action possibly at work. Treatment proved effective wherefore the authors hope that further studies will be carried out in order to increase our knowledge of the modulation and regulation of the immune response, a primary element in the management of these disorders which is at present only experimental.
作者报告了一例由抗血小板抗体引起血小板减少的慢性淋巴细胞白血病病例。事实证明,针对这种病症的常规治疗无效,于是开始采用大剂量静脉注射免疫球蛋白治疗(连续五天每天按0.4 g/kg体重给药),尽管这种作用机制尚未完全明了,但人们认为它可增加血小板计数。观察到实验室参数出现了有趣的变化,尤其是那些与电免疫电泳和免疫固定有关的参数,这些变化可能有助于更好地理解为解释可能起作用的作用机制而提出的各种假说。治疗证明是有效的,因此作者希望开展进一步研究,以增进我们对免疫反应调节和调控的了解,免疫反应是目前仅处于实验阶段的这些病症治疗中的一个主要因素。